Gilead Sciences, Inc.

RHUMBLINE ADVISERS GILD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,271,079

Value ($000)

278,752

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	278,752	0.2%	2,271,079	12/31/2025
2025 Q3	11/6/2025	258,393	0.2%	2,327,866	9/30/2025
2025 Q2	8/12/2025	259,820	0.2%	2,343,468	6/30/2025
2025 Q1	5/29/2025	252,688	0.2%	2,255,140	3/31/2025
2024 Q4	5/29/2025	214,631	0.2%	2,323,602	12/31/2024
2024 Q3	11/12/2024	198,142	0.2%	2,363,341	9/30/2024
2024 Q2	8/1/2024	168,746	0.2%	2,459,500	6/30/2024
2024 Q1	5/9/2024	180,234	0.2%	2,460,538	3/31/2024
2023 Q4	2/8/2024	228,625	0.2%	2,822,190	12/31/2023
2023 Q3	11/9/2023	214,486	0.2%	2,862,109	9/30/2023
2023 Q2	8/8/2023	214,992	0.2%	2,789,574	6/30/2023
2023 Q1	5/11/2023	231,714	0.3%	2,792,750	3/31/2023
2022 Q4	2/14/2023	234,953	0.3%	2,736,789	12/31/2022
2022 Q3	11/10/2022	166,192	0.2%	2,693,980	9/30/2022
2022 Q2	8/11/2022	138,832	0.2%	2,246,106	6/30/2022
2022 Q1	5/12/2022	127,169	0.2%	2,139,087	3/31/2022
2021 Q4	2/10/2022	152,839	0.2%	2,104,925	12/31/2021
2021 Q3	11/12/2021	144,382	0.2%	2,067,025	9/30/2021
2021 Q2	8/5/2021	146,945	0.2%	2,133,974	6/30/2021
2021 Q1	5/6/2021	145,931	0.2%	2,257,944	3/31/2021
2020 Q4	2/10/2021	138,616	0.2%	2,379,262	12/31/2020
2020 Q3	11/12/2020	158,683	0.2%	2,511,199	9/30/2020
2020 Q2	8/13/2020	193,781	0.3%	2,518,603	6/30/2020
2020 Q1	5/6/2020	168,002	0.4%	2,247,212	3/31/2020
2019 Q4	2/5/2020	143,107	0.2%	2,202,320	12/31/2019
2014 Q2	8/6/2014	221,588	0.7%	2,672,633	6/30/2014
2014 Q1	5/6/2014	195,676	0.6%	2,761,444	3/31/2014
2013 Q4	2/3/2014	207,974	0.6%	2,767,448	12/31/2013